BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poachanukoon O, Kitcharoensakkul M. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial. Clin Ther 2008;30:1870-9. [PMID: 19014842 DOI: 10.1016/j.clinthera.2008.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Axiotakis LG, Szeto B, Gonzalez JN, Caruana FF, Gudis DA, Overdevest JB. Antibiotic adverse effects in paediatric acute rhinosinusitis: Systematic review and meta-analysis. International Journal of Pediatric Otorhinolaryngology 2022. [DOI: 10.1016/j.ijporl.2022.111064] [Reference Citation Analysis]
2 Poachanukoon O, Tangsathapornpong A, Tanuchit S. A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study. Clin Exp Otorhinolaryngol 2015;8:129-35. [PMID: 26045911 DOI: 10.3342/ceo.2015.8.2.129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Soriano F, Giménez MJ, Aguilar L. Cefditoren in upper and lower community-acquired respiratory tract infections. Drug Des Devel Ther 2011;5:85-94. [PMID: 21340042 DOI: 10.2147/DDDT.S9499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Kuehn J, Ismael Z, Long PF, Barker CI, Sharland M. Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials. J Pediatr Pharmacol Ther 2015;20:90-104. [PMID: 25964726 DOI: 10.5863/1551-6776-20.2.90] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
5 Nocon CC, Baroody FM. Acute rhinosinusitis in children. Curr Allergy Asthma Rep 2014;14:443. [PMID: 24700347 DOI: 10.1007/s11882-014-0443-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Yoon YK, Park CS, Kim JW, Hwang K, Lee SY, Kim TH, Park DY, Kim HJ, Kim DY, Lee HJ, Shin HY, You YK, Park DA, Kim SW. Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections. Infect Chemother 2017;49:326-52. [PMID: 29299900 DOI: 10.3947/ic.2017.49.4.326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
7 Stenner M, Rudack C. Diseases of the nose and paranasal sinuses in child. GMS Curr Top Otorhinolaryngol Head Neck Surg 2014;13:Doc10. [PMID: 25587370 DOI: 10.3205/cto000113] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Barberán J, Aguilar L, Giménez MJ. Update on the clinical utility and optimal use of cefditoren. Int J Gen Med 2012;5:455-64. [PMID: 22675264 DOI: 10.2147/IJGM.S25989] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Biedenbach DJ, Jones RN. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations. Diagn Microbiol Infect Dis. 2009;64:202-212. [PMID: 19321284 DOI: 10.1016/j.diagmicrobio.2009.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Lee JE, Han DH, Won TB, Rhee CS. A Randomized, Double-blinded, Open Label Study of the Efficacy and Safety of Cefcapene Pivoxil and Amoxicillin·Clavulanate in Acute Presumed Bacterial Rhinosinusitis. Clin Exp Otorhinolaryngol 2011;4:83-7. [PMID: 21716955 DOI: 10.3342/ceo.2011.4.2.83] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Pansa P, Hsia Y, Bielicki J, Lutsar I, Walker AS, Sharland M, Folgori L. Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-Analysis. Drugs 2018;78:231-44. [PMID: 29218501 DOI: 10.1007/s40265-017-0850-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Peters AT, Spector S, Hsu J, Hamilos DL, Baroody FM, Chandra RK, Grammer LC, Kennedy DW, Cohen NA, Kaliner MA, Wald ER, Karagianis A, Slavin RG; Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol 2014;113:347-85. [PMID: 25256029 DOI: 10.1016/j.anai.2014.07.025] [Cited by in Crossref: 97] [Cited by in F6Publishing: 76] [Article Influence: 13.9] [Reference Citation Analysis]